Translating Landmark and Meta-Analyses Trials in CGM to the Front Lines of Diabetes Care: Focus on the Role of Sensor-Based Technology to Improve Time in Range and Interpretation of Ambulatory Glucose Profiles. The Evidence for CGM to Improve Safety, Outcomes, HbA1c Target Goal Attainment and Patient Satisfaction in Persons with Diabetes

Session Type
INDUSTRY SESSION
Date
19.02.2020, Wednesday
Session Time
14:30 - 16:00
Channel
Rome
Lecture Time
14:50 - 15:20
Presenter
  • Richard M. Bergenstal, United States of America
Authors
  • Richard M. Bergenstal, United States of America